1430 related articles for article (PubMed ID: 17868686)
1. Filling a hole in cytochrome P450 BM3 improves substrate binding and catalytic efficiency.
Huang WC; Westlake AC; Maréchal JD; Joyce MG; Moody PC; Roberts GC
J Mol Biol; 2007 Oct; 373(3):633-51. PubMed ID: 17868686
[TBL] [Abstract][Full Text] [Related]
2. A single mutation in cytochrome P450 BM3 changes substrate orientation in a catalytic intermediate and the regiospecificity of hydroxylation.
Oliver CF; Modi S; Sutcliffe MJ; Primrose WU; Lian LY; Roberts GC
Biochemistry; 1997 Feb; 36(7):1567-72. PubMed ID: 9048540
[TBL] [Abstract][Full Text] [Related]
3. Expression, purification, and characterization of Bacillus subtilis cytochromes P450 CYP102A2 and CYP102A3: flavocytochrome homologues of P450 BM3 from Bacillus megaterium.
Gustafsson MC; Roitel O; Marshall KR; Noble MA; Chapman SK; Pessegueiro A; Fulco AJ; Cheesman MR; von Wachenfeldt C; Munro AW
Biochemistry; 2004 May; 43(18):5474-87. PubMed ID: 15122913
[TBL] [Abstract][Full Text] [Related]
4. Imidazolyl carboxylic acids as mechanistic probes of flavocytochrome P-450 BM3.
Noble MA; Quaroni L; Chumanov GD; Turner KL; Chapman SK; Hanzlik RP; Munro AW
Biochemistry; 1998 Nov; 37(45):15799-807. PubMed ID: 9843385
[TBL] [Abstract][Full Text] [Related]
5. Functional interactions in cytochrome P450BM3: flavin semiquinone intermediates, role of NADP(H), and mechanism of electron transfer by the flavoprotein domain.
Murataliev MB; Klein M; Fulco A; Feyereisen R
Biochemistry; 1997 Jul; 36(27):8401-12. PubMed ID: 9204888
[TBL] [Abstract][Full Text] [Related]
6. Control of the stereo-selectivity of styrene epoxidation by cytochrome P450 BM3 using structure-based mutagenesis.
Huang WC; Cullis PM; Raven EL; Roberts GC
Metallomics; 2011 Apr; 3(4):410-6. PubMed ID: 21240430
[TBL] [Abstract][Full Text] [Related]
7. Protein engineering of the cytochrome P450 monooxygenase from Bacillus megaterium.
Urlacher VB; Schmid RD
Methods Enzymol; 2004; 388():208-24. PubMed ID: 15289074
[No Abstract] [Full Text] [Related]
8. Oxygen activation and electron transfer in flavocytochrome P450 BM3.
Ost TW; Clark J; Mowat CG; Miles CS; Walkinshaw MD; Reid GA; Chapman SK; Daff S
J Am Chem Soc; 2003 Dec; 125(49):15010-20. PubMed ID: 14653735
[TBL] [Abstract][Full Text] [Related]
9. Active site substitution A82W improves the regioselectivity of steroid hydroxylation by cytochrome P450 BM3 mutants as rationalized by spin relaxation nuclear magnetic resonance studies.
Rea V; Kolkman AJ; Vottero E; Stronks EJ; Ampt KA; Honing M; Vermeulen NP; Wijmenga SS; Commandeur JN
Biochemistry; 2012 Jan; 51(3):750-60. PubMed ID: 22208729
[TBL] [Abstract][Full Text] [Related]
10. Roles of key active-site residues in flavocytochrome P450 BM3.
Noble MA; Miles CS; Chapman SK; Lysek DA; MacKay AC; Reid GA; Hanzlik RP; Munro AW
Biochem J; 1999 Apr; 339 ( Pt 2)(Pt 2):371-9. PubMed ID: 10191269
[TBL] [Abstract][Full Text] [Related]
11. Functional interactions in cytochrome P450BM3. Fatty acid substrate binding alters electron-transfer properties of the flavoprotein domain.
Murataliev MB; Feyereisen R
Biochemistry; 1996 Nov; 35(47):15029-37. PubMed ID: 8942669
[TBL] [Abstract][Full Text] [Related]
12. Structural basis for the properties of two single-site proline mutants of CYP102A1 (P450BM3).
Whitehouse CJ; Yang W; Yorke JA; Rowlatt BC; Strong AJ; Blanford CF; Bell SG; Bartlam M; Wong LL; Rao Z
Chembiochem; 2010 Dec; 11(18):2549-56. PubMed ID: 21110374
[TBL] [Abstract][Full Text] [Related]
13. Selective hydroxylation of highly branched fatty acids and their derivatives by CYP102A1 from Bacillus megaterium.
Budde M; Morr M; Schmid RD; Urlacher VB
Chembiochem; 2006 May; 7(5):789-94. PubMed ID: 16566047
[TBL] [Abstract][Full Text] [Related]
14. Altering the regioselectivity of the subterminal fatty acid hydroxylase P450 BM-3 towards gamma- and delta-positions.
Dietrich M; Do TA; Schmid RD; Pleiss J; Urlacher VB
J Biotechnol; 2009 Jan; 139(1):115-7. PubMed ID: 18984016
[TBL] [Abstract][Full Text] [Related]
15. Electron transfer in flavocytochrome P450 BM3: kinetics of flavin reduction and oxidation, the role of cysteine 999, and relationships with mammalian cytochrome P450 reductase.
Roitel O; Scrutton NS; Munro AW
Biochemistry; 2003 Sep; 42(36):10809-21. PubMed ID: 12962506
[TBL] [Abstract][Full Text] [Related]
16. The bacterial P450 BM3: a prototype for a biocatalyst with human P450 activities.
Yun CH; Kim KH; Kim DH; Jung HC; Pan JG
Trends Biotechnol; 2007 Jul; 25(7):289-98. PubMed ID: 17532492
[TBL] [Abstract][Full Text] [Related]
17. Site-directed mutagenesis of the putative distal helix of peroxygenase cytochrome P450.
Matsunaga I; Ueda A; Sumimoto T; Ichihara K; Ayata M; Ogura H
Arch Biochem Biophys; 2001 Oct; 394(1):45-53. PubMed ID: 11566026
[TBL] [Abstract][Full Text] [Related]
18. Cobaltocene-mediated catalytic monooxygenation using holo and heme domain cytochrome P450 BM3.
Udit AK; Arnold FH; Gray HB
J Inorg Biochem; 2004 Sep; 98(9):1547-50. PubMed ID: 15337607
[TBL] [Abstract][Full Text] [Related]
19. Engineered alkane-hydroxylating cytochrome P450(BM3) exhibiting nativelike catalytic properties.
Fasan R; Chen MM; Crook NC; Arnold FH
Angew Chem Int Ed Engl; 2007; 46(44):8414-8. PubMed ID: 17886313
[No Abstract] [Full Text] [Related]
20. Use of kinetic isotope effects to delineate the role of phenylalanine 87 in P450(BM-3).
Rock DA; Boitano AE; Wahlstrom JL; Rock DA; Jones JP
Bioorg Chem; 2002 Apr; 30(2):107-18. PubMed ID: 12020135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]